Affiliation:
1. From the Departments of Medicine, Montreal Heart Institute (G.K., H.G., J.L.R.); the Institut de recherches cliniques de Montréal (S.P., S.M.); the Department of Pharmacology (S.P., C.G., C.L., S.M.) and the Faculty of Pharmacy (A.A.), University of Montreal; and the University of Toronto (J.L.R.), Canada.
Abstract
Background
—
The role of kinins in the cardioprotective effects of ACE inhibitors remains controversial.
Methods and Results
—
Right ventricular pressure overload in rabbits was produced by pulmonary artery banding for 21 days. Rabbits were untreated, or they received the ACE inhibitor ramipril with or without bradykinin B
1
and B
2
receptor blockers or the angiotensin (Ang) II type I (AT
1
) receptor blocker losartan. Pulmonary artery banding caused right ventricular hypertrophy, depressed papillary muscle contractility, and loss of Ang II contractile effects because of a signaling defect downstream of AT
1
receptors. Paradoxically, AT
1
receptor density and G protein α subunits αq and αi1/2 increased. Inotropic responsiveness to the α-receptor agonist phenylephrine was normal. Ramipril preserved cardiac contractility, but this effect was attenuated by simultaneous use of kinin receptor blockers. Ramipril also maintained responsiveness to Ang II and prevented AT
1
receptor and G protein upregulation. The simultaneous use of a kinin receptor blocker attenuated but did not prevent upregulation in the AT
1
receptor and G protein. Losartan had no effect on baseline contractility, but it maintained cardiac inotropic responsiveness to Ang II, prevented upregulation of AT
1
receptors, but did not modify G protein upregulation.
Conclusions
—
Pressure overload of the right ventricle decreases contractility, uncouples AT
1
receptors to downstream signaling pathways, and changes the expression of components of the AT
1
receptor signaling pathway. Ramipril attenuates these effects via kinins. Interventions that prevent local increases in Ang II or block AT
1
receptors also prevent decreased responsiveness of the AT
1
receptor in this model.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献